Catalyst Pharmaceuticals, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | $0.19 | $0.21 | $0.20 |
Q2 2024 | 3 | $0.22 | $0.24 | $0.23 |
Q3 2024 | 5 | $0.29 | $0.32 | $0.30 |
Q4 2024 | 3 | $0.26 | $0.29 | $0.28 |
Q1 2025 | 4 | $0.28 | $0.30 | $0.29 |
Q2 2025 | 4 | $0.34 | $0.37 | $0.35 |
Q3 2025 | 4 | $0.34 | $0.37 | $0.35 |
Q4 2025 | 4 | $0.38 | $0.41 | $0.40 |
Catalyst Pharmaceuticals, Inc. Earnings Date And Information
Catalyst Pharmaceuticals, Inc. last posted its earnings results on Wednesday, August 7th, 2024. The company reported $0.56 earnings per share for the quarter, topping analysts' consensus estimates of $0.42 by $0.14. The company had revenue of 122.71 M for the quarter and had revenue of 398.20 M for the year. Catalyst Pharmaceuticals, Inc. has generated $1 earnings per share over the last year ($0.63 diluted earnings per share) and currently has a price-to-earnings ratio of 33.92. Catalyst Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based on prior year's report dates.
Catalyst Pharmaceuticals, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/07/2024 | Q2 2024 | $0.42 | $0.35 | -0.07 | $111.77 M | $122.71 M |
05/08/2024 | Q1 2024 | $0.34 | $0.20 | -0.14 | $98.51 M | |
02/28/2024 | Q4 2023 | $0.48 | $0.33 | -0.15 | $110.57 M | |
11/08/2023 | Q3 2023 | -$0.24 | -$0.29 | -0.05 | $100.37 M | $102.69 M |
08/09/2023 | Q2 2023 | $0.25 | $0.36 | 0.11 | $91.71 M | $99.58 M |
05/10/2023 | Q1 2023 | $0.32 | $0.28 | -0.04 | $85.37 M | |
04/24/2023 | Q4 2022 | $0.24 | $60.76 M | |||
11/09/2022 | Q3 2022 | $0.19 | $0.20 | 0.01 | $53.69 M | $57.24 M |
08/09/2022 | Q2 2022 | $0.17 | $0.20 | 0.03 | $53.11 M | |
05/10/2022 | Q1 2022 | $0.14 | $0.12 | -0.02 | $43.09 M | |
03/16/2022 | Q4 2021 | $0.12 | $0.09 | -0.03 | $38.18 M | $38.31 M |
11/09/2021 | Q3 2021 | $0.10 | $0.10 | 0 | $34.59 M | $35.95 M |
08/09/2021 | Q2 2021 | $0.09 | $0.12 | 0.03 | $31.51 M | $36.37 M |
05/10/2021 | Q1 2021 | $0.09 | $0.07 | -0.02 | $30.21 M | |
03/15/2021 | Q4 2020 | $0.09 | $0.11 | 0.02 | $30.11 M | $31.01 M |
11/09/2020 | Q3 2020 | $0.09 | $0.42 | 0.33 | $31.50 M | $29.32 M |
08/10/2020 | Q2 2020 | $0.09 | $0.09 | 0 | $29.48 M | $29.60 M |
05/11/2020 | Q1 2020 | $0.09 | $0.10 | 0.01 | $29.14 M | |
03/16/2020 | Q4 2019 | $0.10 | $0.08 | -0.02 | $29.40 M | $30.12 M |
11/12/2019 | Q3 2019 | $0.11 | $0.13 | 0.02 | $33.19 M | $30.90 M |
Catalyst Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Catalyst Pharmaceuticals, Inc.'s earnings date?
Catalyst Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates.
-
Did Catalyst Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Catalyst Pharmaceuticals, Inc. (:CPRX) reported $0.56 earnings per share (EPS) to beat the analysts' consensus estimate of $0.42 by $0.14.
-
How can I listen to Catalyst Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Catalyst Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Catalyst Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Catalyst Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does Catalyst Pharmaceuticals, Inc. generate each year?
Catalyst Pharmaceuticals, Inc. (:CPRX) has a recorded annual revenue of $398.20 M.
-
How much profit does Catalyst Pharmaceuticals, Inc. generate each year?
Catalyst Pharmaceuticals, Inc. (:CPRX) has a recorded net income of $398.20 M. Catalyst Pharmaceuticals, Inc. has generated $0.67 earnings per share over the last four quarters.
-
What is Catalyst Pharmaceuticals, Inc.'s price-to-earnings ratio?
Catalyst Pharmaceuticals, Inc. (:CPRX) has a price-to-earnings ratio of 33.92 and price/earnings-to-growth ratio is 0.79.